Higher close as oil rebounds

Crude oil prices rebounded in late afternoon trading to lift the markets to a modestly higher close with the Dow rising 17 points to 18,547. Nasdaq gained 15 points to 5,260.


On the upside


The Food and Drug Administration granted accelerated approval for Clovis Oncology's (Nasdaq: CLVS) new drug application for rucaparib.


Daktronics (Nasdaq: DAKT) reported higher first quarter earnings and revenue that topped analyst estimates.


Capstone Turbine's (Nasdaq: CPST) distributor in Belarus and Russia won another order for a C1000 Signature Series microturbine.


On the downside


Kirkland (Nasdaq: KIRK) widened losses for the second quarter.


Investors locked in profits on Tokai Pharmaceuticals (Nasdaq: TKAI).


Profit taking weighed down shares of Nvatel Wireless (Nasdaq: MIFI).


In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 rose 4 points to 2,186. Bitcoin slipped $2 to $581.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.